LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | XMD11-85h | 3.33 | uM | LJP6 | 2 | P20 | 72 | hr | 1389 | 4980 | 5447 | 0.9141 | 0.9109 |
| MCF7 | XMD11-85h | 3.33 | uM | LJP6 | 3 | P20 | 72 | hr | 1389 | 4705 | 5740 | 0.8196 | 0.8148 |
| MCF7 | XMD11-85h | 10 | uM | LJP6 | 1 | P19 | 72 | hr | 1389 | 1518 | 5147 | 0.2949 | 0.0481 |
| MCF7 | XMD11-85h | 10 | uM | LJP6 | 2 | P19 | 72 | hr | 1389 | 2823 | 5447 | 0.5182 | 0.4329 |
| MCF7 | XMD11-85h | 10 | uM | LJP6 | 3 | P19 | 72 | hr | 1389 | 2954 | 5740 | 0.5146 | 0.4457 |
| MCF7 | XMD16-144 | 0.04 | uM | LJP5 | 1 | M12 | 72 | hr | 1389 | 2038 | 5772 | 0.3531 | 0.2051 |
| MCF7 | XMD16-144 | 0.04 | uM | LJP5 | 3 | M12 | 72 | hr | 1389 | 2114 | 6038 | 0.3501 | 0.2191 |
| MCF7 | XMD16-144 | 0.12 | uM | LJP5 | 1 | M11 | 72 | hr | 1389 | 1795 | 5772 | 0.3110 | 0.1329 |
| MCF7 | XMD16-144 | 0.12 | uM | LJP5 | 3 | M11 | 72 | hr | 1389 | 1739 | 6038 | 0.2880 | 0.1118 |
| MCF7 | XMD16-144 | 0.37 | uM | LJP5 | 1 | M10 | 72 | hr | 1389 | 1747 | 5772 | 0.3026 | 0.1180 |
| MCF7 | XMD16-144 | 0.37 | uM | LJP5 | 3 | M10 | 72 | hr | 1389 | 1861 | 6038 | 0.3082 | 0.1479 |
| MCF7 | XMD16-144 | 1.11 | uM | LJP5 | 1 | M09 | 72 | hr | 1389 | 1798 | 5772 | 0.3115 | 0.1338 |
| MCF7 | XMD16-144 | 1.11 | uM | LJP5 | 3 | M09 | 72 | hr | 1389 | 1811 | 6038 | 0.2999 | 0.1333 |
| MCF7 | XMD16-144 | 3.33 | uM | LJP5 | 1 | M08 | 72 | hr | 1389 | 1923 | 5772 | 0.3331 | 0.1715 |
| MCF7 | XMD16-144 | 3.33 | uM | LJP5 | 3 | M08 | 72 | hr | 1389 | 1797 | 6038 | 0.2976 | 0.1291 |
| MCF7 | XMD16-144 | 10 | uM | LJP5 | 1 | M07 | 72 | hr | 1389 | 598 | 5772 | 0.1036 | -0.3364 |
| MCF7 | XMD16-144 | 10 | uM | LJP5 | 3 | M07 | 72 | hr | 1389 | 845 | 6038 | 0.1399 | -0.2090 |
| MCF7 | Erlotinib | 0.04 | uM | LJP5 | 1 | M24 | 72 | hr | 1389 | 5272 | 5772 | 0.9133 | 0.9137 |
| MCF7 | Erlotinib | 0.04 | uM | LJP5 | 3 | M24 | 72 | hr | 1389 | 5098 | 6038 | 0.8443 | 0.8465 |
| MCF7 | Erlotinib | 0.12 | uM | LJP5 | 1 | M23 | 72 | hr | 1389 | 5478 | 5772 | 0.9490 | 0.9497 |
| MCF7 | Erlotinib | 0.12 | uM | LJP5 | 3 | M23 | 72 | hr | 1389 | 5963 | 6038 | 0.9875 | 0.9882 |
| MCF7 | Erlotinib | 0.37 | uM | LJP5 | 1 | M22 | 72 | hr | 1389 | 6196 | 5772 | 1.0734 | 1.0701 |
| MCF7 | Erlotinib | 0.37 | uM | LJP5 | 3 | M22 | 72 | hr | 1389 | 6216 | 6038 | 1.0294 | 1.0275 |
| MCF7 | Erlotinib | 1.11 | uM | LJP5 | 1 | M21 | 72 | hr | 1389 | 6476 | 5772 | 1.1219 | 1.1151 |
| MCF7 | Erlotinib | 1.11 | uM | LJP5 | 3 | M21 | 72 | hr | 1389 | 6746 | 6038 | 1.1172 | 1.1073 |